Aurinia Pharmaceuticals, Inc. (AUPH)
15.28
-0.56
(-3.54%)
USD |
NASDAQ |
May 15, 16:00
15.26
-0.02
(-0.10%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Liabilities (Quarterly) : 156.37M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 48.99M |
| Edesa Biotech, Inc. | 2.188M |
| ProMIS Neurosciences, Inc. | 6.694M |
| Medicus Pharma Ltd. | 4.299M |
| Kiniksa Pharmaceuticals International Plc | 219.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 724.00M |
| Shareholders Equity (Quarterly) | 567.63M |
| Debt to Equity Ratio | 0.1209 |
| Current Ratio | 5.548 |
| Net Debt Paydown Yield | 0.11% |